Search details
1.
Antibody-based immunotherapy of cancer.
Cell
; 148(6): 1081-4, 2012 Mar 16.
Article
in English
| MEDLINE | ID: mdl-22424219
2.
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Ann Surg Oncol
; 30(2): 1099-1109, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36305992
3.
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Gastroenterology
; 160(4): 1359-1372.e13, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33307028
4.
Combining Three-Dimensional Modeling with Artificial Intelligence to Increase Specificity and Precision in Peptide-MHC Binding Predictions.
J Immunol
; 205(7): 1962-1977, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32878910
5.
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies.
Semin Cancer Biol
; 65: 28-37, 2020 10.
Article
in English
| MEDLINE | ID: mdl-31866479
6.
The role of fibroblast activation protein in health and malignancy.
Cancer Metastasis Rev
; 39(3): 783-803, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32601975
7.
Status of Cancer Care at Network Sites of the Nation's Academic Cancer Centers.
J Natl Compr Canc Netw
; 19(6): 726-732, 2021 03 11.
Article
in English
| MEDLINE | ID: mdl-33706258
8.
CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer.
PLoS Comput Biol
; 14(4): e1006935, 2018 06.
Article
in English
| MEDLINE | ID: mdl-31002670
9.
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy.
Int J Mol Sci
; 20(1)2019 Jan 04.
Article
in English
| MEDLINE | ID: mdl-30621125
10.
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
Cancer
; 124(11): 2337-2346, 2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29579325
11.
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
Cancer Immunol Immunother
; 67(2): 195-207, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29043413
12.
Protein network construction using reverse phase protein array data.
Methods
; 124: 89-99, 2017 07 15.
Article
in English
| MEDLINE | ID: mdl-28651964
13.
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.
Cancer Immunol Immunother
; 66(12): 1529-1544, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28770278
14.
Predictive biomarkers for checkpoint inhibitor-based immunotherapy.
Lancet Oncol
; 17(12): e542-e551, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27924752
15.
G-DOC Plus - an integrative bioinformatics platform for precision medicine.
BMC Bioinformatics
; 17(1): 193, 2016 Apr 30.
Article
in English
| MEDLINE | ID: mdl-27130330
16.
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.
Blood
; 123(19): 3016-26, 2014 May 08.
Article
in English
| MEDLINE | ID: mdl-24652987
17.
Building better magic bullets--improving unconjugated monoclonal antibody therapy for cancer.
Nat Rev Cancer
; 7(9): 701-6, 2007 09.
Article
in English
| MEDLINE | ID: mdl-17721434
18.
The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.
Mol Ther
; 22(2): 278-291, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24113515
19.
Cancer immunology for the clinician.
Clin Adv Hematol Oncol
; 13(5): 299-306, 2015 May.
Article
in English
| MEDLINE | ID: mdl-26352774
20.
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
FASEB J
; 27(2): 581-9, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23104982